■ Schizophrenia and sleep disorders: links, risks, and management challenges
Rachel E Kaskie, Bianca Graziano, Fabio Ferrarelli
Nat Sci Sleep. 2017; vol 9: 227–239.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614792/
■ Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendation for the first episode
Dolores Keating, Stephen McWilliams, Ian Schneider et al
BMJ Open. 2017; vol 7(1): e013881
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223704/
■ NICE v. SIGN on psychosis and schizophrenia: same roots, similar guildelines, different interpretations
T Kendall, C J Whittington, E Kuipers
The British Journal of Psychiatry 2016, vol 208 (4): 316-319
http://bjp.rcpsych.org/content/208/4/316
■ Adherence to NICE guidance on lifestyle advice for people with schizophrenia: a survey
L Swaby, D Hind, R Gossage-Worral et al
BJPsych Bulletin 2017, 137-14
http://pb.rcpsych.org/content/41/3/137
■ Resting vagal activity in schizophrenia: meta-analysis of heart rate variability as a potential endophenotype
A Clamor, T M Lincoln, J F Thayer, J Koening
The British Journal of Psychiatry 2016, vol 208 (1): 9-16
http://bjp.rcpsych.org/content/208/1/9
■ Safety, tolerability, and risk associated with first-and second-generation antipsychotics: a state-of-the-art clinical review
Marco Solmi, Andrea Murru, Isabella Pacchiarotti, et al
Ther Clin Risk Manag. 2017; 13: 757–777
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499790/
■ Dow do people experiencing, schizophrenia spectrum disorders or other psychotic disorders use the internet to get information on their mental health: Literature review and recommendations
Murielle Villani, Viviane Kovess-Masfety
JMIR Ment Health. 2017 vol 4(1): e1.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241504/
■ Schizophrenia: neuroinflammation, neurodegeneration or neurodevelopment? A genetic overview
G B Polho, V J R de Paula
Medicina USP 2017, vol 96 (1)
https://www.revistas.usp.br/revistadc/article/view/122542/125358
■ Genetics of schizophrenia: overview of methods, findings and limitations
Mads G. Henriksen, Julie Nordgaard, Lennart B. Jansson
Front Hum Neurosci. 2017; vol 11: 322
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480258/
■ Validação da Recovery Assessment Scale (RAS) no Brasil para avaliar a capacidade de superação das pessoas com esquizofrenia
Silva, Tiago R. et al.
- bras. psiquiatr., Mar 2017, vol.66, no.1, p.1-8
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0047-20852017000100001&lng=en&nrm=iso
■ Schizophrenia and the neurodevelopmental continuum: evidence from genomics
Michael J. Owen, Michael C. O’Donovan
World Psychiatry. 2017 Oct; 16(3): 227–235
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608820/
■ Rehabilitation interventions to promote recovery from schizophrenia: a systematic review
Laurent Morin, Nicolas Franck
Front Psychiatry. 2017; vol 8: 100
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467004/
■ El juicio de realidad y mundos posibles en personas con esquizofrenia.
Figueroa, Alicia et al.
Rev. chil. neuro-psiquiatr., Jul 2017, vol.55, no.3, p.195-204
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-92272017000300195&lng=en&nrm=iso
■ Esquizofrenia resistente al tratamiento: ¿hemos tomado una decisión?
Barquero-Madrigal, Alejandro.
Rev. chil. neuro-psiquiatr., 2017, vol.55, no.2, p.85-92
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-92272017000200003&lng=en&nrm=iso
■ Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis
Britta Galling, Alexandra Roldán, Katsuhiko Hagi et al
World Psychiatry. 2017 Feb; 16(1): 77–89
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269492/
■ Psychotropic prescriptions for the treatment of schizophrenia in an outpatient clinic.
Okpataku, Christopher Izehinosen and Tawani, David
Trends Psychiatry Psychother., Sept 2017, vol.39, no.3, p.165-17
■ Asenapine for the treatment of psychotic disorders: a systematic review and meta-analysis
Catherine Orr, Santosh Deshpande, Sonja Sawh, Philip M. Jones, Kamini Vasudev
Can J Psychiatry. 2017 Feb; 62(2): 123–137
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298524/
■ From clozapine to cognitive remediation: a review of biological and psychosocial treatments for violence in schizophrenia
Jason Quinn, Nathan J. Kolla
Can J Psychiatry. 2017 Feb; 62(2): 94–101
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298523/
■ What is the place of clozapine in the treatment of early psychosis in Canada?
Richard Williams, Ashok Malla, Marc-Andre Roy et al
Can J Psychiatry. 2017 Feb; 62(2): 109–114.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298522/
■ Variation in use of antipsychotic medications in nursing homes in the United States: a systematic review
H Cioltan, S Alshehri, C Howe et al
BMC Geriatr 2017, vol 17: 32
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267409/
■ Association between antipsychotics and cardiovascular adverse events: A systematic review
Silva, Ana Amancio Santos Da et al.
Rev. Assoc. Med. Bras., Mar 2017, vol.63, no.3, p.261-267
■ Clinicians adherence to clinical practice eguidelines for cardiac function monitoring during antipsychotic treatment: a retrospective report on 434 patients with severe mental illness
Mirko Manchia, Giorgio Firinu, Bernardo Carpiniello, Federica Pinna
BMC Psychiatry. 2017; vol 17: 121
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374645/
■ Efectos secundarios de la medicación antipsicótica y calidad de vida en pacientes con esquizofrenia latinoamericanos.
Caqueo-Urízar, Alejandra, Urzúa, Alfonso and Rus-Calafell, Mar
Ter Psicol, Abr 2017, vol.35, no.1, p.111-114
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-48082017000100010&lng=en&nrm=iso
■ Long-acting injectable antipsychotic in schizophrenia: literature review and practival perspective, with a focus on aripiprazole once-monthly
Enrico Biagi, Enrico Capuzzi, Fabrizia Colmegna et AL
Adv Ther. 2017; vol 34(5): 1036–1048
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427126/
■ Efficacy and safety of lurasidone in adolescents with schizophrenia: a 6-week, randomized placebo-controlled study
Robert Goldman, Antony Loebel, Josephine Cucchiaro, Ling Deng, Robert L. Findling
J Child Adolesc Psychopharmacol. 2017, vol 27(6): 516–525
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568017/
■ Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis
Davy Vancampfort, Joseph Firth, Felipe B. Schuch et al
World Psychiatry. 2017 Oct; 16(3): 308–31
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608847/
■ Mating, sexual selection, and the evolution of schizophrenia
Marco Del Giudice
World Psychiatry. 2017 Jun; 16(2): 141–142
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428186/
■ The current conceptualization of negative symptoms in schizophrenia
Stephen R. Marder, Silvana Galderisi
World Psychiatry. 2017, vol 16(1): 14–24
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269507/
■ Evidence that communication impairment in schizophrenia is associated with generalized poor task performance
Anne M. Merrill, Nicole R. Karcher, David C. Cicero et al
Psychiatry Res. 2017, vol 249: 172–179
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452682/
■ Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysi
A Egerton, G Modinos, D Ferrera, P McGuire
Transl Psychiatry. 2017 , vol 7(6): e1147
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537645/
■ Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: a prospective birth cohort study
Stephen A. Metcalf, Peter B. Jones, Tanja Nordstrom et al
Brain Behav Immun. 2017, vol 59: 253–259
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176002/
■ Trends in standardized mortality among individuals with schizophrenia, 1933-2012: a population-based, repeated cross-sectional study
Evgenia Gatov, Laura Rosella, Maria Chiu, Paul A. Kurdyak
CMAJ. 2017 , vol 189(37): E1177–E1187
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602497/
■ Assessing the risk for suicide in schizophrenia according to migration, ethnicity and geographical ancestry
Nuwan C. Hettige, Ali Bani-Fatemi, James L. Kennedy, Vincenzo De Luca
BMC Psychiatry. 2017; 17: 63.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301397/
■ Using video-annotation software to identify interactions in group therapies for schizophrenia: assessing reliability and associations with outcomes
Stavros Orfanos, Syeda Ferhana Akther, Muhammad Abdul-Basit, Rosemarie McCabe, Stefan Priebe
BMC Psychiatry. 2017; 17: 65
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301334/
■ Relevance of a subjective quality of life questionnaire for long-term homeless persons with schizophrenia
- Girard, A. Tinland, J. P. Bonin, F. Olive et al
BMC Psychiatry. 2017; 17: 72
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314634/
■ Dilemma of treating schizophrenia during pregnancy: a case series and a review of literature
Andreea Teodorescu, Petru Ifteni, Marius Alexandru Moga, Victoria
Burtea, Nicusor Bigiu
BMC Psychiatry. 2017; vol 17: 311
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576383/
■ Neurometabolic abnormalities in schizophrenia and depression observed with magnetic resonance spectroscopy at 7 T
Reggie Taylor, Elizabeth A. Osuch, Betsy Schaefer et al
BJPsych Open. 2017, vol 3(1): 6–11
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288640/
■ Community-based psychosocial interventions for people with schizophrenia in low and middle-income countries: systematic review and meta-analysis
Laura Asher, Vikram Patel, Mary J De Silva
BMC Psychiatry. 2017; vol 17: 355.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661919/
■ Shared decision making PLUS – a cluster-randomized trial with inpatients suffering from schizophrenia (SDM-PLUS)
Johannes Hamann, Fabian Holzhüter, Lynne Stecher, Stephan Heres
BMC Psychiatry. 2017; vol 17: 78.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324213/
■ Treatment outcomes in schizophrenia: qualitative study of the views of family carers
Joanne Lloyd, Helen Lloyd, Ray Fitzpatrick, Michele Peters
BMC Psychiatry. 2017; vol 17: 266.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521073/
■ A case of GABAR antibodies in schizophrenia
Ida S. Haussleiter, Klaus-Peter Wandinger, Georg Juckel
BMC Psychiatry. 2017; vol 17: 9.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223378/
■ A pilot study on feasibility, acceptance and effectiveness of metacognitive-oriented social skills training in schizophrenia
Felix Inchausti, Nancy V. García-Poveda, Alejandro Ballesteros-Prados et al
BMC Psychiatry. 2017; 17: 217.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468977/
■ Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? A systematic review
Amy L. Gillespie, Ruta Samanaite, Jonathan Mill, Alice Egerton, James H. MacCabe
BMC Psychiatry. 2017; 17: 12
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237235/
■ Predictors of long term use of psychiatric services of patients with recent-onset schizophrenia: 12 years follow-up
Víðir Sigrúnarson, Rolf W. Gråwe, Stian Lydersen, Gunnar Morken
BMC Psychiatry. 2017; vol 17: 18
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237502/
■ Obesity in individuals with schizophrenia: a case controlled study in Scotland
Isobel M. Cameron, Ross J. Hamilton, Gordon Fernie, Stephen A. MacGillivray
BJPsych Open. 2017, vol 3(5): 254–256
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643876/
■ Lifestyle factors and the metabolic syndrome in Schizophrenia: a cross-sectional study
A Heald, J Pendlebury, S Anderson et al
Annals of General Psychiatry 2017, vol 16: 12
https://annals-general-psychiatry.biomedcentral.com/articles/10.1186/s12991-017-0134-6
■ Prevalência de síndrome metabólica em pacientes com esquizofrenia refratária
Batista de Freitas, Pedro Henrique et al
Cienc. enferm., Set 2016, vol.22, no.3, p.11-24.
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95532016000300011&lng=en&nrm=iso
■ Cognitive-behavioral therapy for schizophrenia: an overview on efficacy, recent trends and neurobiological findings.
Candida, Maristela et al.
MedicalExpress (São Paulo, online), Oct 2016, vol.3, no.5
■ Pesquisa em psicanálise: questões a partir do transitivismo com pacientes esquizofrênicos.
Jardim, Luciane Loss.
Ágora (Rio J.), Mar 2017, vol.20, no.1, p.103-117
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-14982017000100103&lng=en&nrm=iso
■ Esquizofrenia refratária: qualidade de vida e fatores associados.
Freitas, Pedro Henrique Batista de et al.
Acta paul. enferm., Fev 2016, vol.29, no.1, p.60-68
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-21002016000100060&lng=en&nrm=iso
■ Dopamine 2 receptor genes are associated with raised blood glucose in schizophrenia
Bruce R. Lawford, Mark Barnes, C. Phillip Morris et al
Can J Psychiatry. 2016 May; 61(5): 291–297
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841287/
■ Do the trajectories of bipolar disorder and schizophrenia follow a universal staging model?
Anne Duffy, Gin S. Malhi, Paul Grof
Can J Psychiatry. 2017 Feb; 62(2): 115–122
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298521/
■ Psicose e esquizofrenia: efeitos das mudanças nas classificações psiquiátricas sobre a abordagem clínica e teórica das doenças mentais.
Tenório, Fernando.
Hist. cienc. saude-Manguinhos, Dez 2016, vol.23, no.4, p.941-963
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-59702016000400941&lng=en&nrm=iso
■ Frontal lobe alterations in schizophrenia: a review.
Mubarik, Ateeq and Tohid, Hassaan
Trends Psychiatry Psychother., Dec 2016, vol.38, no.4, p.198-20
■ A experiência subjetiva do uso de psicotrópicos na perspectiva de pessoas com diagnóstico de esquizofrenia.
Benini, Iara Scaranelo Penteado and Leal, Erotildes Maria
Rev. latinoam. psicopatol. fundam., Mar 2016, vol.19, no.1, p.30-42
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47142016000100030&lng=en&nrm=iso
■ Influência das características sociodemográficas e clínicas na qualidade de vida dos indivíduos com esquizofrenia
Pinho, Lara Guedes de, Pereira, Anabela and Chaves, Cláudia
Rev. esc. enferm. USP, 2017, vol.51
■ Is semantic verbal fluency impairment explained by executive function deficits in schizophrenia?.
Berberian, Arthur A. et al.
Rev. Bras. Psiquiatr., June 2016, vol.38, no.2, p.121-126
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462016000200121&lng=en&nrm=iso
■ Effect of transcranial direct current stimulation (tDCS) over the prefrontal cortex combined with cognitive training for treating schizophrenia: a sham-controlled randomized clinical trial
Shiozawa, Pedro et al.
Trends Psychiatry Psychother., Sept 2016, vol.38, no.3, p.175-177
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2237-60892016000300175&lng=en&nrm=iso
■ Family burden in schizophrenia: the influence of age of onset and negative symptoms
Mantovani, Lucas M. et al.
Trends Psychiatry Psychother., June 2016, vol.38, no.2, p.96-99
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2237-60892016000200096&lng=en&nrm=iso
■ La rehabilitación cognitiva para pacientes con esquizofrenia de larga data: un desafío para los equipos de salud.
Loubat O, Margarita, Gárate M, Roberto and Cuturrufo A, Nelson
Rev. chil. neuro-psiquiatr., Dic 2016, vol.54, no.4, p.299-308
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-92272016000400005&lng=en&nrm=iso
■ La esquizofrenia atenuada revisitada: la pérdida de la evidencia natural.
Figueroa C, Gustavo.
Rev. chil. neuro-psiquiatr., Jun 2015, vol.53, no.2, p.117-126
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-92272015000200007&lng=en&nrm=iso
■ Association of carbohydrate and fatty acid intake with anthropometric parameters in subjects with schizophrenia and bipolar disorders.
Santillana T, Natalia, Cavieres F, Álvaro and Vega S, Claudia
Rev. méd. Chile, Set 2016, vol.144, no.9, p.1159-1163
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000900010&lng=en&nrm=iso
■ Las perturbaciones del objeto psiquiátrico y sus determinantes: el caso de la desaparición de la esquizofrenia
Múzquiz Jiménez, Álvaro.
Rev. Asoc. Esp. Neuropsiq., Dic 2016, vol.36, no.130, p.515-533
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-57352016000200013&lng=es&nrm=iso
■ La esquizofrenia en el medio penitenciario.
Fuentes, Marina and Fernández, Eva Maria
Rev. Asoc. Esp. Neuropsiq., Dic 2016, vol.36, no.130, p.405-42
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-57352016000200007&lng=es&nrm=iso
■ Elaboración y validación de una Escala de Apoyo Profesional para cuidadores de pacientes con esquizofrenia
Ribé, José Miguel et al.
Rev. Asoc. Esp. Neuropsiq., Jun 2016, vol.36, no.129, p.29-44
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-57352016000100003&lng=es&nrm=iso
■ Propuesta de un modelo de respuesta de los delirios esquizofrénicos a los antipsicóticos
Martínez-Pastor, Carlos J. and Real Román, Vicente
Rev. Asoc. Esp. Neuropsiq., Jun 2016, vol.36, no.129, p.15-28
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-57352016000100002&lng=es&nrm=iso
■ Analysis of errors in verbal fluency tasks in patients with chronic schizophrenia.
Galaverna, Flavia et al.
Eur. J. Psychiat., Dec 2016, vol.30, no.4, p.305-320
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-61632016000400006&lng=es&nrm=iso
■ Comparisons of verbal fluency brain correlates between adults and adolescents suffering from schizophrenia spectrum disorders: a pilot study.
Urben, Sébastien et al.
Eur. J. Psychiat., Dec 2016, vol.30, no.4, p.249-257
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-61632016000400003&lng=es&nrm=iso
■ Do the generalised cognitive deficits observed in schizophrenia indicate a rapidly-ageing brain?.
Dragovic, Milan, Fajgelj, Stanislav and Panickacheril John, Alexander
Eur. J. Psychiat., June 2016, vol.30, no.2, p.141-148
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-61632016000200005&lng=es&nrm=iso
■ Are idiom comprehension difficulties in patients with schizophrenia due to working memory and executive deficits?.
Lacroix, Agnès et al.
Eur. J. Psychiat., June 2016, vol.30, no.2, p.119-129
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-61632016000200003&lng=es&nrm=iso
■ Clinical trial designs of new medicinal products for treating schizophrenia: discussion of EMA’s Guideline and a Better Long Term Trial Design
Jiang, Haibiao and Zhang, Jingjing
Eur. J. Psychiat., Mar 2016, vol.30, no.1, p.29-40
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-61632016000100002&lng=es&nrm=iso
■ Explorando el potencial de aprendizaje de personas con esquizofrenia en distintas condiciones psicopatológicas
González Pando, David, Beltrán García, Palma and Martínez Suárez, Pedro Carlos
Clínica y Salud, Jul 2016, vol.27, no.2, p.81-88
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-52742016000200006&lng=es&nrm=iso
■ Evaluation of the validity and utility of a transdiagnostic psychosis dimension emcompassing schizophrenia and bipolar disorder
U Reininghaus, J R Böhnke, G Hosang et al
The British Journal of Psychiatry 2016, vol 209 (2): 107-113
http://bjp.rcpsych.org/content/209/2/107
■ Effectiveness of group body psychotherapy for negative symptoms of schizophrenia: multicentre randomized controlled trial
S Priebe, M Savill, T Wykes et al
The British Journal of Psychiatry 2016, vol 209 (1): 54-61
http://bjp.rcpsych.org/content/209/1/54
■ Frontal slow-wave activity as a predictor of negative symptoms, cognition and functional capacity in schizophrenia
Y Chen, B Stone-Howell, J C Edgar et al
The British Journal of Psychiatry 2016, vol 208 (2): 160-167
http://bjp.rcpsych.org/content/208/2/160
■ Cultural differences in stigma surrounding schizophrenia: comparison between Central Europe and North Africa
M C Angermeyer, M G Carta, H Matschinger et al
The British Journal of Psychiatry 2016, vol 208 (4): 389-39
http://bjp.rcpsych.org/content/208/4/389
■ VRK2 gene expression in schizophrenia, bipolar and healthy controls
M Tesli, K V Wirgenes, T Hughes et al
The British Journal of Psychiatry 2016, vol 209 (2): 114-120
http://bjp.rcpsych.org/content/209/2/114
■ Virtual reality in assessment and treatment of schizophrenia: a systematic review
Macedo, Mônica, Marques, António and Queirós, Cristina
- bras. psiquiatr., Mar 2015, vol.64, no.1, p.70-81
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0047-20852015000100070&lng=en&nrm=iso
■ Investigation of cognition in schizophrenia: psychometric properties of instruments for assessing working memory updating.
Berberian, Arthur A. et al.
- bras. psiquiatr., Sept 2015, vol.64, no.3, p.238-24
■ Refraction and eye anterior segment parameters in schizophrenic patients
Cumurcu, Tongabay et al.
Arq. Bras. Oftalmol., June 2015, vol.78, no.3, p.180-184
■ Avaliação das Atitudes de Estudantes da Área da Saúde em relação a Pacientes Esquizofrênicos
Ferreira, Fernanda Nunes et al.
Rev. bras. educ. med., Dez 2015, vol.39, no.4, p.542-549
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-55022015000400542&lng=en&nrm=iso
■ by Dr Paulo Fernando Leite
Cardiologia – Centro Médico Unimed BH
Rua Gonçalves Dias 202
Belo Horizonte/MG/Brasil
31 30033306 / 40204020
CRMMG: 7026
Email: pfleite1873@gmail.com